{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:50:23Z","timestamp":1791103823967,"version":"4.1.0"},"reference-count":311,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T00:00:00Z","timestamp":1754179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,4]]},"abstract":"Abstract<\/jats:title>\n \n Introduction<\/jats:title>\n Treatment of erectile dysfunction is based on pharmacotherapy for most patients.<\/jats:p>\n <\/jats:sec>\n \n Aim<\/jats:title>\n To review the current data on pharmacotherapy for erectile dysfunction based on efficacy, psychosocial outcomes, and safety outcomes.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A review of the literature was undertaken by the committee members. All related articles were critically analyzed and discussed, and consensus statements were developed after presentation at the 2024 ICSM.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Eight recommendations are provided with the corresponding level of evidence and grade of recommendation.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The management of erectile dysfunction should be personalized to address the psychosocial needs and expectations of both the patient and their partner. PDE5 inhibitors remain the first-line treatment for most men, while intracavernosal injections, vacuum erection devices, and penile prostheses serve as second-line options, with treatment decisions guided by patient preferences. Key recommendations are summarized in table 1.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/sxmrev\/qeaf035","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:02:37Z","timestamp":1751443357000},"page":"513-537","source":"Crossref","is-referenced-by-count":18,"title":["Evolving medical management of erectile dysfunction: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1014-090X","authenticated-orcid":false,"given":"Noah","family":"Stern","sequence":"first","affiliation":[{"name":"Department of Surgery, Division of Urology, North York General Hospital , Toronto, ON, M2K 1E1 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4884-2288","authenticated-orcid":false,"given":"Petar","family":"Bajic","sequence":"additional","affiliation":[{"name":"Men\u2019s Health Section, Cleveland Clinic Glickman Urological Institute , Cleveland, OH 44106 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Urology, Schulich School of Medicine and Dentistry, Western University , London, ON, N6A 5C1 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2347-9504","authenticated-orcid":false,"given":"Paolo","family":"Capogrosso","sequence":"additional","affiliation":[{"name":"Department of Urology, Circolo & Fondazione Macchi Hospital \u2013 ASST Sette Laghi, Department of Medicine and Technical Innovation (DIMIT), University of Insubria , Varese VA, 21100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trustin","family":"Domes","sequence":"additional","affiliation":[{"name":"Division of Urology, University of Saskatchewan , Saskatoon, SK, S7M 2W2 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3552-5400","authenticated-orcid":false,"given":"Eduardo P","family":"Miranda","sequence":"additional","affiliation":[{"name":"Division of Urology, Centro Universit\u00e1rio Christus - UNICHRISTUS , Fortaleza CE, 60160-230 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Mulhall","sequence":"additional","affiliation":[{"name":"Sexual and Reproductive Medicine Program, Urology Service, Memorial Sloan Kettering Cancer Center , New York, NY, 10022 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4319-4434","authenticated-orcid":false,"given":"Bruno","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Department of Urology, Clinical Hospital FMUSP , S\u00e3o Paulo SP, 05403-010 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pignanelli","sequence":"additional","affiliation":[{"name":"Department of Urology, Albany Medical College , Albany, NY, 12208 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W","family":"Pastuszak","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, University of Utah School of Medicine , Salt Lake City, UT 84132 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Brock","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, Western University , London, ON, N6A 5C1 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,3]]},"reference":[{"issue":"24","key":"2026020606574998700_ref1","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","article-title":"Erectile dysfunction","volume":"342","author":"Lue","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"2026020606574998700_ref2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1152\/physrev.1995.75.1.191","article-title":"Physiology of penile erection","volume":"75","author":"Andersson","year":"1995","journal-title":"Physiol Rev"},{"issue":"4","key":"2026020606574998700_ref3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ucl.2005.08.007","article-title":"Physiology of penile erection and pathophysiology of erectile dysfunction","volume":"32","author":"Dean","year":"2005","journal-title":"Urol Clin North Am"},{"issue":"1_Part_2","key":"2026020606574998700_ref4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1743-6109.2009.01624.x","article-title":"Anatomy, physiology, and pathophysiology of erectile dysfunction","volume":"7","author":"Gratzke","year":"2010","journal-title":"J Sex Med"},{"issue":"2","key":"2026020606574998700_ref5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41585-018-0109-7","article-title":"The mechanisms and potential of stem cell therapy for penile fibrosis","volume":"16","author":"Milenkovic","year":"2019","journal-title":"Nat Rev Urol"},{"issue":"6683","key":"2026020606574998700_ref6","doi-asserted-by":"crossref","first-page":"eade8064","DOI":"10.1126\/science.ade8064","article-title":"Corpora cavernosa fibroblasts mediate penile erection","volume":"383","author":"Guimaraes","year":"2024","journal-title":"Science"},{"issue":"1","key":"2026020606574998700_ref7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bju.15313","article-title":"Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analyses","volume":"128","author":"Mostafaei","year":"2021","journal-title":"BJU Int"},{"issue":"5","key":"2026020606574998700_ref8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.eururo.2013.08.023","article-title":"A systematic review of the association between erectile dysfunction and cardiovascular disease","volume":"65","author":"Gandaglia","year":"2014","journal-title":"Eur Urol"},{"issue":"12","key":"2026020606574998700_ref9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.amjcard.2005.07.006","article-title":"The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease","volume":"96","author":"Montorsi","year":"2005","journal-title":"Am J Cardiol"},{"issue":"4","key":"2026020606574998700_ref10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.esxm.2019.08.005","article-title":"Hypoxia-induced phenotypic transformation of corpus Cavernosum smooth muscle cells after cavernous nerve crush injury by down-regulating P38 mitogen-activated protein kinase expression","volume":"7","author":"Chen","year":"2019","journal-title":"Sex Med"},{"issue":"5","key":"2026020606574998700_ref11","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1095\/biolreprod.106.059642","article-title":"Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat","volume":"76","author":"Ferrini","year":"2007","journal-title":"Biol Reprod"},{"issue":"2","key":"2026020606574998700_ref12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000474815","article-title":"Impotence due to corporeal veno-occlusive dysfunction: long-term follow-up of venous surgery","volume":"21","author":"Wespes","year":"1992","journal-title":"Eur Urol"},{"issue":"Supplement_3","key":"2026020606574998700_ref13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1743-6109.2008.01195.x","article-title":"Mechanisms of penile fibrosis","volume":"6","author":"Gonzalez-Cadavid","year":"2009","journal-title":"J Sex Med"},{"issue":"1","key":"2026020606574998700_ref14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.21037\/tau.2016.11.01","article-title":"Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction","volume":"6","author":"Campbell","year":"2017","journal-title":"Transl Androl Urol"},{"issue":"3","key":"2026020606574998700_ref15","first-page":"141","article-title":"A comprehensive review of erectile dysfunction in men with diabetes","volume":"123","author":"Kamenov","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"2026020606574998700_ref16","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s40618-023-02136-x","article-title":"Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study","volume":"46","author":"Corona","year":"2023","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"2026020606574998700_ref17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/sxmrev\/qead056","article-title":"Optimal timing of surgical intervention for penile fracture: a narrative review of the modern literature","volume":"12","author":"Bernstein","year":"2024","journal-title":"Sex Med Rev"},{"issue":"1","key":"2026020606574998700_ref18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1743-6109.2008.00923.x","article-title":"Correlation of the erectile dysfunction with lesions of cerebrovascular accidents","volume":"6","author":"Jeon","year":"2009","journal-title":"J Sex Med"},{"issue":"9","key":"2026020606574998700_ref19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/sj.sc.3101198","article-title":"Sexual function in spinal cord lesioned men","volume":"39","author":"Biering-Sorensen","year":"2001","journal-title":"Spinal Cord"},{"issue":"3","key":"2026020606574998700_ref20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jsxm.2016.11.325","article-title":"Sexual rehabilitation after treatment for prostate cancer-part 1: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015)","volume":"14","author":"Salonia","year":"2017","journal-title":"J Sex Med"},{"issue":"11","key":"2026020606574998700_ref21","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00384-017-2826-4","article-title":"Sexual dysfunction following rectal cancer surgery","volume":"32","author":"Celentano","year":"2017","journal-title":"Int J Color Dis"},{"issue":"3","key":"2026020606574998700_ref22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.sxmr.2017.11.003","article-title":"Surgical factors associated with male and female sexual dysfunction after radical cystectomy: what do we know and how can we improve outcomes?","volume":"6","author":"Pederzoli","year":"2018","journal-title":"Sex Med Rev"},{"issue":"1","key":"2026020606574998700_ref23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.sxmr.2017.06.004","article-title":"Erectile dysfunction following pelvic fracture urethral injury","volume":"6","author":"Johnsen","year":"2018","journal-title":"Sex Med Rev"},{"issue":"12","key":"2026020606574998700_ref24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11910-022-01240-4","article-title":"Updates on the diagnosis and treatment of peripheral autonomic neuropathies","volume":"22","author":"Lamotte","year":"2022","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4_Part_1","key":"2026020606574998700_ref25","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/j.1743-6109.2009.01601.x","article-title":"Age-related changes in general and sexual health in middle-aged and older men: results from the European male ageing study (EMAS)","volume":"7","author":"Corona","year":"2010","journal-title":"J Sex Med"},{"issue":"1","key":"2026020606574998700_ref26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.eururo.2013.08.048","article-title":"A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review","volume":"65","author":"Isidori","year":"2014","journal-title":"Eur Urol"},{"issue":"2","key":"2026020606574998700_ref27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hypogonadism in middle-aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"2026020606574998700_ref28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-019-0087-y","article-title":"Paediatric and adult-onset male hypogonadism","volume":"5","author":"Salonia","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2026020606574998700_ref29","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1743-6109.2012.02735.x","article-title":"Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA)","volume":"10","author":"Maggi","year":"2013","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1677\/joe.1.06233","article-title":"The endocrinology of sexual arousal","volume":"186","author":"Bancroft","year":"2005","journal-title":"J Endocrinol"},{"issue":"9","key":"2026020606574998700_ref31","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/dme.13403","article-title":"High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies","volume":"34","author":"Kouidrat","year":"2017","journal-title":"Diabet Med"},{"issue":"1","key":"2026020606574998700_ref32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.2047-2927.2013.00162.x","article-title":"Aberrant expression of Wnt family contributes to the pathogenesis of diabetes-induced erectile dysfunction","volume":"2","author":"Shin","year":"2014","journal-title":"Andrology"},{"issue":"9","key":"2026020606574998700_ref33","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/17512433.2021.1938548","article-title":"The role of testosterone treatment in patients with metabolic disorders","volume":"14","author":"Corona","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"2026020606574998700_ref34","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/jsm.12885","article-title":"The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies","volume":"12","author":"Besiroglu","year":"2015","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5527\/wjn.v4.i3.379","article-title":"Erectile dysfunction in chronic kidney disease: from pathophysiology to management","volume":"4","author":"Papadopoulou","year":"2015","journal-title":"World J Nephrol"},{"issue":"10","key":"2026020606574998700_ref36","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1111\/jsm.12648","article-title":"Calcification of the internal pudendal artery and development of erectile dysfunction in adenine-induced chronic kidney disease: a sentinel of systemic vascular changes","volume":"11","author":"Maio","year":"2014","journal-title":"J Sex Med"},{"issue":"2","key":"2026020606574998700_ref37","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s12072-021-10270-y","article-title":"Prevalence and risk factors of erectile dysfunction in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"17","author":"Yoo","year":"2023","journal-title":"Hepatol Int"},{"key":"2026020606574998700_ref38","volume-title":"Spinal Cord Injury","author":"World Health Organization","year":"2013"},{"issue":"12","key":"2026020606574998700_ref39","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12121985","article-title":"Sexuality, intimacy, and reproductive health after spinal cord injury","volume":"12","author":"Zizzo","year":"2022","journal-title":"J Pers Med"},{"issue":"10","key":"2026020606574998700_ref40","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1089\/neu.2004.21.1371","article-title":"Targeting recovery: priorities of the spinal cord-injured population","volume":"21","author":"Anderson","year":"2004","journal-title":"J Neurotrauma"},{"issue":"2","key":"2026020606574998700_ref41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/sj.sc.3100482","article-title":"Ejaculatory stimulation, quality of semen and reproductive aspects in spinal cord injured men","volume":"36","author":"Le Chapelain","year":"1998","journal-title":"Spinal Cord"},{"key":"2026020606574998700_ref42","volume-title":"Physiology of Penile Erection and Pathophysiology of Erectile Dysfunction","author":"Wein","year":"2012","edition":"10th"},{"issue":"6","key":"2026020606574998700_ref43","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1212\/WNL.51.6.1629","article-title":"Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury","volume":"51","author":"Derry","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"2026020606574998700_ref44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/1531-8249(199907)46:1<15::AID-ANA5>3.0.CO;2-U","article-title":"Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury","volume":"46","author":"Giuliano","year":"1999","journal-title":"Sildenafil Study Group Ann Neurol"},{"issue":"7","key":"2026020606574998700_ref45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/BRS.0b013e3181695040","article-title":"Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury","volume":"33","author":"Giuliano","year":"2008","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"2026020606574998700_ref46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1212\/01.wnl.0000194260.43583.32","article-title":"Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury","volume":"66","author":"Giuliano","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"2026020606574998700_ref47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/sj.sc.3101011","article-title":"Quality of life in patients with spinal cord injury receiving Viagra (sildenafil citrate) for the treatment of erectile dysfunction","volume":"38","author":"Hultling","year":"2000","journal-title":"Spinal Cord"},{"issue":"4","key":"2026020606574998700_ref48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.sxmr.2017.01.007","article-title":"Efficacy and safety of sildenafil in men with sexual dysfunction and spinal cord injury","volume":"5","author":"Ohl","year":"2017","journal-title":"Sex Med Rev"},{"issue":"5","key":"2026020606574998700_ref49","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/10790268.2008.11753647","article-title":"A placebo-controlled, multicenter, randomized, double-blind, flexible-dose, two-way crossover study to evaluate the efficacy and safety of sildenafil in men with traumatic spinal cord injury and erectile dysfunction","volume":"31","author":"Ergin","year":"2008","journal-title":"J Spinal Cord Med"},{"issue":"6","key":"2026020606574998700_ref50","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1111\/andr.12878","article-title":"Performance and safety of treatment options for erectile dysfunction in patients with spinal cord injury: a review of the literature","volume":"8","author":"Afferi","year":"2020","journal-title":"Andrology"},{"issue":"3","key":"2026020606574998700_ref51","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1080\/10790268.2003.11753687","article-title":"The effects of sildenafil on the cardiovascular response in men with spinal cord injury at or above the sixth thoracic level","volume":"26","author":"Ethans","year":"2003","journal-title":"J Spinal Cord Med"},{"issue":"1","key":"2026020606574998700_ref52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41394-018-0137-9","article-title":"A randomized double-blind, placebo-controlled, cross-over trial assessing the effect of tadalafil (Cialis) on the cardiovascular response in men with complete spinal cord injury above the sixth thoracic level: a pilot study","volume":"4","author":"Ethans","year":"2018","journal-title":"Spinal Cord Ser Cases"},{"issue":"2","key":"2026020606574998700_ref53","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/sj.sc.3101950","article-title":"Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men","volume":"45","author":"Soler","year":"2007","journal-title":"Spinal Cord"},{"issue":"6","key":"2026020606574998700_ref54","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2605.2009.01033.x","article-title":"Sildenafil efficacy in erectile dysfunction secondary to spinal cord injury depends on the level of cord injuries","volume":"33","author":"Khorrami","year":"2010","journal-title":"Int J Androl"},{"issue":"2","key":"2026020606574998700_ref55","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000020278","article-title":"Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients","volume":"38","author":"Schmid","year":"2000","journal-title":"Eur Urol"},{"issue":"3","key":"2026020606574998700_ref56","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/sxmrev\/qeae020","article-title":"A comprehensive history of injection therapy for erectile dysfunction, 1982-2023","volume":"12","author":"Porst","year":"2024","journal-title":"Sex Med Rev"},{"issue":"3","key":"2026020606574998700_ref57","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0022-5347(17)53037-2","article-title":"Neurourologic abnormalities in multiple sclerosis","volume":"128","author":"Goldstein","year":"1982","journal-title":"J Urol"},{"issue":"3","key":"2026020606574998700_ref58","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","article-title":"Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension","volume":"71","author":"Hussain","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"2026020606574998700_ref59","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S0302-2838(02)00054-4","article-title":"Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease","volume":"41","author":"Raffaele","year":"2002","journal-title":"Eur Urol"},{"issue":"4","key":"2026020606574998700_ref60","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0022-5347(17)45825-3","article-title":"Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients","volume":"135","author":"Sidi","year":"1986","journal-title":"J Urol"},{"issue":"3","key":"2026020606574998700_ref61","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0003-9993(94)90028-0","article-title":"Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction","volume":"75","author":"Chao","year":"1994","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"2026020606574998700_ref62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0002-9149(00)00896-1","article-title":"Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton consensus panel","volume":"86","author":"DeBusk","year":"2000","journal-title":"Am J Cardiol"},{"issue":"12B","key":"2026020606574998700_ref63","doi-asserted-by":"publisher","first-page":"85M","DOI":"10.1016\/j.amjcard.2005.11.008","article-title":"Sexual dysfunction and cardiac risk (the second Princeton consensus conference)","volume":"96","author":"Kostis","year":"2005","journal-title":"Am J Cardiol"},{"issue":"8","key":"2026020606574998700_ref64","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.mayocp.2012.06.015","article-title":"The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease","volume":"87","author":"Nehra","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2026020606574998700_ref65","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/jsxmed\/qdad163","article-title":"Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health","volume":"21","author":"Kloner","year":"2024","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref66","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile dysfunction: AUA guideline","volume":"200","author":"Burnett","year":"2018","journal-title":"J Urol"},{"issue":"10","key":"2026020606574998700_ref67","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2026020606574998700_ref68","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1136\/heartjnl-2016-310746","article-title":"Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction","volume":"103","author":"Andersson","year":"2017","journal-title":"Heart"},{"issue":"12","key":"2026020606574998700_ref69","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jacc.2021.01.045","article-title":"Association of Phosphodiesterase-5 inhibitors versus Alprostadil with survival in men with coronary artery disease","volume":"77","author":"Andersson","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2026020606574998700_ref70","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/jsxmed\/qdac005","article-title":"Effect of phosphodiesterase type 5 inhibitors on major adverse cardiovascular events and overall mortality in a large nationwide cohort of men with erectile dysfunction and cardiovascular risk factors: a retrospective, observational study based on healthcare claims and national death index data","volume":"20","author":"Kloner","year":"2023","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref71","doi-asserted-by":"publisher","first-page":"H1263","DOI":"10.1152\/ajpheart.00324.2002","article-title":"Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits","volume":"283","author":"Ockaili","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"30","key":"2026020606574998700_ref72","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.2174\/138161209789206980","article-title":"PDE5 inhibitors in non-urological conditions","volume":"15","author":"Vlachopoulos","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"4","key":"2026020606574998700_ref73","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1365-2125.2011.04034.x","article-title":"Anti-platelet therapy: phosphodiesterase inhibitors","volume":"72","author":"Gresele","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2026020606574998700_ref74","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11255-022-03442-8","article-title":"The impact of renal transplantation on sexual function in males with end-stage kidney disease: a systematic review and meta-analysis","volume":"55","author":"Miron","year":"2023","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"2026020606574998700_ref75","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41443-020-0295-8","article-title":"Prevalence of erectile dysfunction in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"33","author":"Pizzol","year":"2021","journal-title":"Int J Impot Res"},{"issue":"2","key":"2026020606574998700_ref76","doi-asserted-by":"publisher","first-page":"155","DOI":"10.21037\/tau.2018.09.04","article-title":"Erectile dysfunction in renal failure and transplant patients","volume":"8","author":"Fiuk","year":"2019","journal-title":"Transl Androl Urol"},{"issue":"4","key":"2026020606574998700_ref77","doi-asserted-by":"publisher","first-page":"F671","DOI":"10.1152\/ajprenal.00042.2016","article-title":"The role of cGMP and its signaling pathways in kidney disease","volume":"311","author":"Shen","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"2026020606574998700_ref78","first-page":"407","article-title":"Phosphodiesterase-5 (PDE5) inhibitors In the Management of Erectile Dysfunction","volume":"38","author":"Huang","year":"2013","journal-title":"P T"},{"issue":"1","key":"2026020606574998700_ref79","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1523-1755.2004.00739.x","article-title":"The pharmacokinetics and hemodynamics of sildenafil citrate in male hemodialysis patients","volume":"66","author":"Grossman","year":"2004","journal-title":"Kidney Int"},{"issue":"6","key":"2026020606574998700_ref80","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/ndt\/15.6.926","article-title":"Timing of sildenafil therapy in dialysis patients-lessons following an episode of hypotension","volume":"15","author":"Mohamed","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"2026020606574998700_ref81","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1093\/ndt\/gfq243","article-title":"Effects of sildenafil and vardenafil on erectile dysfunction and health-related quality of life in haemodialysis patients: a prospective randomized crossover study","volume":"25","author":"Turk","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2026020606574998700_ref82","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ijir.2010.32","article-title":"Effects of sildenafil and vardenafil treatments on sleep quality and depression in hemodialysis patients with erectile dysfunction","volume":"23","author":"Solak","year":"2011","journal-title":"Int J Impot Res"},{"issue":"Supplement_1","key":"2026020606574998700_ref83","doi-asserted-by":"publisher","first-page":"hcad069.769","DOI":"10.1093\/qjmed\/hcad069.769","article-title":"Efficacy and safety of different modalities for treatment of erectile dysfunction in chronic renal failure patients","volume":"116","author":"Zakher","year":"2023","journal-title":"QJM Int J Med"},{"issue":"4","key":"2026020606574998700_ref84","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/JU.0000000000001577","article-title":"Renal transplantation improves erectile function in patients with end-stage renal disease: a systematic review and meta-analysis","volume":"205","author":"Pyrgidis","year":"2021","journal-title":"J Urol"},{"issue":"5","key":"2026020606574998700_ref85","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41443-021-00419-6","article-title":"Effects of renal transplantation on erectile dysfunction: a systematic review and meta-analysis","volume":"34","author":"Rahman","year":"2022","journal-title":"Int J Impot Res"},{"issue":"2","key":"2026020606574998700_ref86","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1053\/j.ajkd.2004.10.012","article-title":"The efficacy of sildenafil for the treatment of erectile dysfunction in male peritoneal dialysis patients","volume":"45","author":"Mahon","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"2026020606574998700_ref87","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1097\/01.ASN.0000034201.97937.3E","article-title":"Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction","volume":"13","author":"Seibel","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2026020606574998700_ref88","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.ajkd.2006.04.061","article-title":"Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: a randomized, double-blind, placebo-controlled, crossover trial","volume":"48","author":"Sharma","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2026020606574998700_ref89","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.transproceed.2006.02.076","article-title":"Efficacy and safety of vardenafil in renal transplant recipients with erectile dysfunction","volume":"38","author":"Demir","year":"2006","journal-title":"Transplant Proc"},{"issue":"3","key":"2026020606574998700_ref90","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","article-title":"European Association of Urology guidelines on sexual and reproductive Health-2021 update: male sexual dysfunction","volume":"80","author":"Salonia","year":"2021","journal-title":"Eur Urol"},{"issue":"10","key":"2026020606574998700_ref91","doi-asserted-by":"publisher","first-page":"310","DOI":"10.5489\/cuaj.7572","article-title":"Canadian Urological Association guideline: erectile dysfunction","volume":"15","author":"Domes","year":"2021","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"2026020606574998700_ref92","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1742-1241.2007.01636.x","article-title":"Integrating partners into erectile dysfunction treatment: improving the sexual experience for the couple","volume":"62","author":"Dean","year":"2008","journal-title":"Int J Clin Pract"},{"key":"2026020606574998700_ref93","first-page":"101033","article-title":"Association between erectile dysfunction, cardiovascular risk factors, and coronary artery disease: role of exercise stress testing and international index of erectile function (IIEF-5) questionnaire","volume":"40","author":"Ahmed","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"9","key":"2026020606574998700_ref94","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.jsxm.2018.06.005","article-title":"The 2018 revision to the process of care model for evaluation of erectile dysfunction","volume":"15","author":"Mulhall","year":"2018","journal-title":"J Sex Med"},{"issue":"1","key":"2026020606574998700_ref95","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/endocrines4010011","article-title":"Does testosterone salvage PDE5i non-responders? A scoping review","volume":"4","author":"Pignanelli","year":"2023","journal-title":"Endocrines"},{"issue":"1","key":"2026020606574998700_ref96","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1743-6109.2010.01956.x","article-title":"Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)","volume":"8","author":"Buvat","year":"2011","journal-title":"J Sex Med"},{"issue":"5","key":"2026020606574998700_ref97","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1743-6109.2010.01824.x","article-title":"Organic vs. psychogenic? The Manichean diagnosis in sexual medicine","volume":"7","author":"Jannini","year":"2010","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref98","doi-asserted-by":"publisher","first-page":"100506","DOI":"10.1016\/j.esxm.2022.100506","article-title":"A modified procedure to diagnose erectile dysfunction using the international index of erectile function (IIEF-6) combined with the premature ejaculation diagnosis tool (PEDT) via an internet survey","volume":"10","author":"Wang","year":"2022","journal-title":"Sex Med"},{"issue":"6","key":"2026020606574998700_ref99","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"issue":"6","key":"2026020606574998700_ref100","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1111\/j.1743-6109.2007.00600.x","article-title":"Validation of the erection hardness score","volume":"4","author":"Mulhall","year":"2007","journal-title":"J Sex Med"},{"issue":"5","key":"2026020606574998700_ref101","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/andr.13175","article-title":"Accurate and time-saving, two-step intracavernosal injection procedure to diagnose psychological erectile dysfunction","volume":"10","author":"Santi","year":"2022","journal-title":"Andrology"},{"issue":"5","key":"2026020606574998700_ref102","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41443-018-0061-3","article-title":"Variability in penile duplex ultrasound international practice patterns, technique, and interpretation: an anonymous survey of ISSM members","volume":"30","author":"Butaney","year":"2018","journal-title":"Int J Impot Res"},{"issue":"7","key":"2026020606574998700_ref103","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1111\/j.1743-6109.2009.01343.x","article-title":"Use and abuse of Rigiscan in the diagnosis of erectile dysfunction","volume":"6","author":"Jannini","year":"2009","journal-title":"J Sex Med"},{"issue":"2","key":"2026020606574998700_ref104","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/01.ju.0000063377.12281.57","article-title":"Deciphering erectile dysfunction drug trials","volume":"170","author":"Mulhall","year":"2003","journal-title":"J Urol"},{"issue":"1","key":"2026020606574998700_ref105","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.sxmr.2018.06.005","article-title":"The serendipitous story of sildenafil: an unexpected oral therapy for erectile dysfunction","volume":"7","author":"Goldstein","year":"2019","journal-title":"Sex Med Rev"},{"issue":"Suppl 3","key":"2026020606574998700_ref106","first-page":"S26","article-title":"Four-year review of sildenafil citrate","volume":"4","author":"McCullough","year":"2002","journal-title":"Rev Urol"},{"issue":"5","key":"2026020606574998700_ref107","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.eururo.2004.01.014","article-title":"The efficacy and safety of flexible-dose vardenafil (levitra) in a broad population of European men","volume":"45","author":"Hatzichristou","year":"2004","journal-title":"Eur Urol"},{"issue":"20","key":"2026020606574998700_ref108","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction. Sildenafil study group","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"2026020606574998700_ref109","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1742-1241.1998.tb08886.x","article-title":"Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil study group","volume":"52","author":"Padma-Nathan","year":"1998","journal-title":"Int J Clin Pract"},{"issue":"4","key":"2026020606574998700_ref110","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0090-4295(98)00586-X","article-title":"Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects","volume":"53","author":"Dinsmore","year":"1999","journal-title":"Urology"},{"issue":"5","key":"2026020606574998700_ref111","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0090-4295(98)00643-8","article-title":"Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies","volume":"53","author":"Montorsi","year":"1999","journal-title":"Urology"},{"issue":"3","key":"2026020606574998700_ref112","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.ijir.3900527","article-title":"Long-term efficacy and safety of oral Viagra (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal","volume":"12","author":"Christiansen","year":"2000","journal-title":"Int J Impot Res"},{"issue":"9","key":"2026020606574998700_ref113","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1742-1241.2000.tb10928.x","article-title":"Sildenafil citrate (Viagra\u00ae) is effective and well tolerated for treating erectile dysfunction of psychogenic or mixed aetiology","volume":"54","author":"Olsson","year":"2000","journal-title":"Int J Clin Pract"},{"issue":"4","key":"2026020606574998700_ref114","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0090-4295(00)00688-9","article-title":"Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction. The Assess-1 study group","volume":"56","author":"Tan","year":"2000","journal-title":"Urology"},{"issue":"4","key":"2026020606574998700_ref115","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.ijir.3900685","article-title":"ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan","volume":"13","author":"Chen","year":"2001","journal-title":"Int J Impot Res"},{"issue":"4","key":"2026020606574998700_ref116","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1023\/A:1012270220064","article-title":"Efficacy results and quality-of-life measures in men receiving sildenafil citrate for the treatment of erectile dysfunction","volume":"10","author":"Giuliano","year":"2001","journal-title":"Qual Life Res"},{"issue":"5","key":"2026020606574998700_ref117","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S0090-4295(01)00945-1","article-title":"Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the erectile dysfunction inventory of treatment satisfaction questionnaire","volume":"57","author":"Lewis","year":"2001","journal-title":"Urology"},{"issue":"1","key":"2026020606574998700_ref118","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1464-410x.2001.00998.x","article-title":"A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction","volume":"87","author":"Meuleman","year":"2001","journal-title":"BJU Int"},{"issue":"S2","key":"2026020606574998700_ref119","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/sj.ijir.3900896","article-title":"Sildenafil citrate (Viagra) in the treatment of men with erectile dysfunction in southern Latin America: a double-blind, randomized, placebo-controlled, parallel-group, multicenter, flexible-dose escalation study","volume":"14","author":"Becher","year":"2002","journal-title":"Int J Impot Res"},{"issue":"S2","key":"2026020606574998700_ref120","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1038\/sj.ijir.3900895","article-title":"Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction in Brazilian and Mexican men","volume":"14","author":"Glina","year":"2002","journal-title":"Int J Impot Res"},{"issue":"S2","key":"2026020606574998700_ref121","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1038\/sj.ijir.3900897","article-title":"Efficacy and safety of oral sildenafil citrate (Viagra) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study","volume":"14","author":"Gomez","year":"2002","journal-title":"Int J Impot Res"},{"issue":"S1","key":"2026020606574998700_ref122","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1038\/sj.ijir.3900970","article-title":"Efficacy and safety of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in Egypt and South Africa","volume":"15","author":"Levinson","year":"2003","journal-title":"Int J Impot Res"},{"issue":"3","key":"2026020606574998700_ref123","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1743-6109.2006.00234.x","article-title":"Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: results from an international, multi-center, double-blind, placebo-controlled trial","volume":"3","author":"Althof","year":"2006","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref124","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0022-5347(05)00418-0","article-title":"Self-esteem, confidence and relationship satisfaction of men with erectile dysfunction treated with sildenafil citrate: a multicenter, randomized, parallel group, double-blind, placebo controlled study in the United States","volume":"175","author":"O'Leary","year":"2006","journal-title":"J Urol"},{"issue":"6","key":"2026020606574998700_ref125","first-page":"1100","article-title":"Efficacy and safety of sildenafil in Asian males with erectile dysfunction and cardiovascular risk","volume":"90","author":"Buranakitjaroen","year":"2007","journal-title":"J Med Assoc Thail"},{"issue":"4","key":"2026020606574998700_ref126","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1471-0528.2006.01228.x","article-title":"Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"114","author":"Heiman","year":"2007","journal-title":"BJOG"},{"issue":"4_Part_2","key":"2026020606574998700_ref127","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1743-6109.2007.00536.x","article-title":"The south Australian couples sildenafil study: double-blind, parallel-group randomized controlled study to examine the psychological and relationship consequences of sildenafil use in couples","volume":"4","author":"Hundertmark","year":"2007","journal-title":"J Sex Med"},{"issue":"6","key":"2026020606574998700_ref128","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/sj.ijir.3901579","article-title":"Sildenafil reduces bother associated with erectile dysfunction: pooled analysis of five randomized, double-blind trials","volume":"19","author":"Seftel","year":"2007","journal-title":"Int J Impot Res"},{"issue":"8","key":"2026020606574998700_ref129","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1111\/j.1743-6109.2008.00879.x","article-title":"Effect of sildenafil citrate on the male sexual experience assessed with the sexual experience questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension","volume":"5","author":"Jones","year":"2008","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref130","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1743-6109.2007.00701.x","article-title":"Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase","volume":"5","author":"Kadioglu","year":"2008","journal-title":"J Sex Med"},{"issue":"4","key":"2026020606574998700_ref131","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/ijir.2008.24","article-title":"Self-esteem, confidence and relationship satisfaction in men with erectile dysfunction: a randomized, parallel-group, double-blind, placebo-controlled study of sildenafil in Mexico","volume":"20","author":"Zonana Farca","year":"2008","journal-title":"Int J Impot Res"},{"issue":"1","key":"2026020606574998700_ref132","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1743-6109.2008.01026.x","article-title":"Self-esteem, confidence, and relationships in Brazilian men with erectile dysfunction receiving sildenafil citrate: a randomized, parallel-group, double-blind, placebo-controlled study in Brazil","volume":"6","author":"Glina","year":"2009","journal-title":"J Sex Med"},{"issue":"5","key":"2026020606574998700_ref133","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jsxm.2016.02.166","article-title":"Efficacy and safety of sildenafil by age in men with erectile dysfunction","volume":"13","author":"Goldstein","year":"2016","journal-title":"J Sex Med"},{"issue":"6","key":"2026020606574998700_ref134","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.esxm.2021.100453","article-title":"Efficacy of the orally disintegrating strip sildenafil for the treatment of erectile dysfunction: a prospective, randomized trial","volume":"9","author":"Sangkum","year":"2021","journal-title":"Sex Med"},{"issue":"12","key":"2026020606574998700_ref135","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.jsxm.2017.10.066","article-title":"Effectiveness and safety of Oro-dispersible sildenafil in a new film formulation for the treatment of erectile dysfunction: comparison between sildenafil 100-mg film-coated tablet and 75-mg Oro-dispersible film","volume":"14","author":"Cocci","year":"2017","journal-title":"J Sex Med"},{"key":"2026020606574998700_ref136","volume-title":"CIALIS (Tadalafil) Tablets Tablets [Package Insert]","author":"U.S. Food and Drug Administration","year":"2007"},{"issue":"1","key":"2026020606574998700_ref137","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.ijir.3900631","article-title":"On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction","volume":"13","author":"Padma-Nathan","year":"2001","journal-title":"Int J Impot Res"},{"issue":"1","key":"2026020606574998700_ref138","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0090-4295(03)00359-5","article-title":"Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial","volume":"62","author":"Porst","year":"2003","journal-title":"Urology"},{"issue":"6","key":"2026020606574998700_ref139","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1464-410X.2004.05049.x","article-title":"Efficacy and safety of tadalafil in a western European population of men with erectile dysfunction","volume":"94","author":"Eardley","year":"2004","journal-title":"BJU Int"},{"issue":"2","key":"2026020606574998700_ref140","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/01.ju.0000132857.39680.ce","article-title":"The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction","volume":"172","author":"Seftel","year":"2004","journal-title":"J Urol"},{"issue":"3","key":"2026020606574998700_ref141","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.eururo.2004.04.026","article-title":"Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction","volume":"46","author":"Skoumal","year":"2004","journal-title":"Eur Urol"},{"issue":"5","key":"2026020606574998700_ref142","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1743-6109.2005.00097.x","article-title":"Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial","volume":"2","author":"Carrier","year":"2005","journal-title":"J Sex Med"},{"issue":"2","key":"2026020606574998700_ref143","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1742-1241.2005.00451.x","article-title":"A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebo-controlled study in Australian men","volume":"59","author":"McMahon","year":"2005","journal-title":"Int J Clin Pract"},{"issue":"3","key":"2026020606574998700_ref144","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2164\/jandrol.04126","article-title":"Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial","volume":"26","author":"Young","year":"2005","journal-title":"J Androl"},{"issue":"6","key":"2026020606574998700_ref145","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1442-2042.2006.01393.x","article-title":"Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in south-east Asian men","volume":"13","author":"Guo","year":"2006","journal-title":"Int J Urol"},{"issue":"3","key":"2026020606574998700_ref146","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1743-6109.2006.00248.x","article-title":"Tolerance to the therapeutic effect of tadalafil does not occur during 6 months of treatment: a randomized, double-blind, placebo-controlled study in men with erectile dysfunction","volume":"3","author":"McMahon","year":"2006","journal-title":"J Sex Med"},{"issue":"4","key":"2026020606574998700_ref147","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.urology.2006.05.001","article-title":"Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled study","volume":"68","author":"Nagao","year":"2006","journal-title":"Urology"},{"issue":"7","key":"2026020606574998700_ref148","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1742-1241.2006.00993.x","article-title":"Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction","volume":"60","author":"Saylan","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"6","key":"2026020606574998700_ref149","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1745-7262.2006.00213.x","article-title":"Efficacy and safety of on demand tadalafil in the treatment of east and southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study","volume":"8","author":"Yip","year":"2006","journal-title":"Asian J Androl"},{"issue":"2","key":"2026020606574998700_ref150","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.eururo.2006.02.052","article-title":"Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"50","author":"Porst","year":"2006","journal-title":"Eur Urol"},{"issue":"1","key":"2026020606574998700_ref151","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/sj.ijir.3901496","article-title":"Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US","volume":"19","author":"Rajfer","year":"2007","journal-title":"Int J Impot Res"},{"issue":"5","key":"2026020606574998700_ref152","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/j.1743-6109.2009.01222.x","article-title":"Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily","volume":"6","author":"Rubio-Aurioles","year":"2009","journal-title":"J Sex Med"},{"issue":"9","key":"2026020606574998700_ref153","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1111\/j.1743-6109.2011.02353.x","article-title":"A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naive to PDE5 inhibitors","volume":"8","author":"Montorsi","year":"2011","journal-title":"J Sex Med"},{"issue":"5","key":"2026020606574998700_ref154","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jsxm.2016.02.171","article-title":"Efficacy of continuous dosing of Tadalafil once daily vs Tadalafil on demand in clinical subgroups of men with erectile dysfunction: a descriptive comparison using the integrated Tadalafil databases","volume":"13","author":"Brock","year":"2016","journal-title":"J Sex Med"},{"key":"2026020606574998700_ref155","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.urology.2017.08.031","article-title":"The efficacy of Tadalafil daily vs on demand in the treatment of erectile dysfunction: a systematic review and meta-analysis","volume":"112","author":"Bansal","year":"2018","journal-title":"Urology"},{"issue":"3","key":"2026020606574998700_ref156","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.esxm.2019.06.006","article-title":"Meta-analysis of the long-term efficacy and tolerance of Tadalafil daily compared with Tadalafil on-demand in treating men with erectile dysfunction","volume":"7","author":"Zhou","year":"2019","journal-title":"Sex Med"},{"issue":"2","key":"2026020606574998700_ref157","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1743-6109.2004.04029.x","article-title":"Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study","volume":"1","author":"Chen","year":"2004","journal-title":"J Sex Med"},{"issue":"4","key":"2026020606574998700_ref158","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.juro.2006.11.037","article-title":"Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"177","author":"McVary","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"2026020606574998700_ref159","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.juro.2008.06.079","article-title":"Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study","volume":"180","author":"Roehrborn","year":"2008","journal-title":"J Urol"},{"issue":"5","key":"2026020606574998700_ref160","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.eururo.2011.08.005","article-title":"Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial","volume":"60","author":"Porst","year":"2011","journal-title":"Eur Urol"},{"issue":"1","key":"2026020606574998700_ref161","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1743-6109.2011.02504.x","article-title":"Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study","volume":"9","author":"Egerdie","year":"2012","journal-title":"J Sex Med"},{"issue":"5","key":"2026020606574998700_ref162","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.eururo.2012.01.013","article-title":"Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial","volume":"61","author":"Oelke","year":"2012","journal-title":"Eur Urol"},{"issue":"4","key":"2026020606574998700_ref163","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.ijir.3900713","article-title":"The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial","volume":"13","author":"Porst","year":"2001","journal-title":"Int J Impot Res"},{"issue":"6","key":"2026020606574998700_ref164","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/j.1939-4640.2002.tb02332.x","article-title":"Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Hellstrom","year":"2002","journal-title":"J Androl"},{"issue":"3","key":"2026020606574998700_ref165","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1368-5031.2004.00128.x","article-title":"Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction","volume":"58","author":"Stief","year":"2004","journal-title":"Int J Clin Pract"},{"issue":"5","key":"2026020606574998700_ref166","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1743-6109.2005.00119.x","article-title":"Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil","volume":"2","author":"Fisher","year":"2005","journal-title":"J Sex Med"},{"issue":"6","key":"2026020606574998700_ref167","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1743-6109.2006.00329.x","article-title":"Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naive men with ED and their partners","volume":"3","author":"Edwards","year":"2006","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref168","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1743-6109.2007.00468.x","article-title":"The efficacy and safety of vardenafil in east Asian men with erectile dysfunction","volume":"4","author":"Chen","year":"2007","journal-title":"J Sex Med"},{"issue":"2","key":"2026020606574998700_ref169","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1743-6109.2006.00426.x","article-title":"Efficacy of vardenafil and influence on self-esteem and self-confidence in patients with severe erectile dysfunction","volume":"4","author":"Martin-Morales","year":"2007","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref170","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1745-7262.2008.00388.x","article-title":"Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction","volume":"10","author":"Tan","year":"2008","journal-title":"Asian J Androl"},{"issue":"1","key":"2026020606574998700_ref171","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1742-1241.2008.01947.x","article-title":"Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study","volume":"63","author":"Rosenberg","year":"2009","journal-title":"Int J Clin Pract"},{"issue":"4_Part_1","key":"2026020606574998700_ref172","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/j.1743-6109.2010.01806.x","article-title":"The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction","volume":"7","author":"Sperling","year":"2010","journal-title":"J Sex Med"},{"issue":"5","key":"2026020606574998700_ref173","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1742-1241.2010.02358.x","article-title":"The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction","volume":"64","author":"Gittelman","year":"2010","journal-title":"Int J Clin Pract"},{"issue":"10","key":"2026020606574998700_ref174","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1111\/j.1743-6109.2011.02352.x","article-title":"Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled study","volume":"8","author":"Martin-Morales","year":"2011","journal-title":"J Sex Med"},{"issue":"6","key":"2026020606574998700_ref175","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/jsm.12496","article-title":"Duration of erection: does it really matter? A randomized, double-blind clinical trial to assess the impact of vardenafil ODT on duration of erection and its correlation with patients' and partners' sexual quality of life and duration of intercourse: the VADEOPEN study","volume":"11","author":"Martin-Morales","year":"2014","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref176","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.esxm.2016.03.027","article-title":"REVITALISE: a large observational study assessing the safety and effectiveness of Vardenafil in men with erectile dysfunction and metabolic syndrome","volume":"4","author":"Shabsigh","year":"2016","journal-title":"Sex Med"},{"issue":"6","key":"2026020606574998700_ref177","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00345-018-2583-1","article-title":"Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: a Bayesian network meta-analysis of randomized controlled trials","volume":"37","author":"Liao","year":"2019","journal-title":"World J Urol"},{"issue":"3","key":"2026020606574998700_ref178","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00345-020-03233-9","article-title":"Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis","volume":"39","author":"Madeira","year":"2021","journal-title":"World J Urol"},{"issue":"3","key":"2026020606574998700_ref179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17512433.2017.1288567","article-title":"Time of onset of vardenafil orodispersible tablet in a real-life setting - looking beyond randomized clinical trials","volume":"10","author":"Capogrosso","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"2026020606574998700_ref180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.juro.2014.12.101","article-title":"Efficacy of Avanafil 15 minutes after dosing in men with erectile dysfunction: a randomized, double-blind, placebo controlled study","volume":"194","author":"Hellstrom","year":"2015","journal-title":"J Urol"},{"issue":"11","key":"2026020606574998700_ref181","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1111\/j.1464-410X.2012.11095.x","article-title":"Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial","volume":"110","author":"Zhao","year":"2012","journal-title":"BJU Int"},{"issue":"4","key":"2026020606574998700_ref182","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1743-6109.2011.02629.x","article-title":"A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction","volume":"9","author":"Goldstein","year":"2012","journal-title":"J Sex Med"},{"issue":"9","key":"2026020606574998700_ref183","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.mayocp.2012.06.016","article-title":"Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus","volume":"87","author":"Goldstein","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2026020606574998700_ref184","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1464-410X.2012.11267.x","article-title":"A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction","volume":"111","author":"Hellstrom","year":"2013","journal-title":"BJU Int"},{"issue":"2","key":"2026020606574998700_ref185","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1517\/14740338.2016.1130126","article-title":"The safety and efficacy of Avanafil, a new 2(nd) generation PDE5i: comprehensive review and meta-analysis","volume":"15","author":"Corona","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"2026020606574998700_ref186","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.juro.2012.03.115","article-title":"Avanafil, a potent and highly selective phosphodiesterase-5 inhibitor for erectile dysfunction","volume":"188","author":"Kotera","year":"2012","journal-title":"J Urol"},{"issue":"8","key":"2026020606574998700_ref187","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/ijcp.12074","article-title":"PDE5 inhibitors: considerations for preference and long-term adherence","volume":"67","author":"Smith","year":"2013","journal-title":"Int J Clin Pract"},{"issue":"5","key":"2026020606574998700_ref188","doi-asserted-by":"publisher","first-page":"1557988319880764","DOI":"10.1177\/1557988319880764","article-title":"Avanafil for the treatment of men with erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Li","year":"2019","journal-title":"Am J Mens Health"},{"issue":"s1","key":"2026020606574998700_ref309","doi-asserted-by":"publisher","first-page":"61S","DOI":"10.1046\/j.0306-5251.2001.00034.x","article-title":"Onset and duration of action of sildenafil for the treatment of erectile dysfunction","volume":"53","author":"Eardley","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"2026020606574998700_ref310"},{"issue":"10","key":"2026020606574998700_ref189","doi-asserted-by":"publisher","first-page":"681","DOI":"10.7326\/0003-4819-157-10-201211200-00004","article-title":"Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial","volume":"157","author":"Spitzer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"2","key":"2026020606574998700_ref190","doi-asserted-by":"publisher","first-page":"591","DOI":"10.21037\/tau.2020.01.13","article-title":"Do testosterone supplements enhance response to phosphodiesterase 5 inhibitors in men with erectile dysfunction and hypogonadism: a systematic review and meta-analysis","volume":"9","author":"Zhu","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"6","key":"2026020606574998700_ref313","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2147\/TCRM.S3336","article-title":"Tadalafil in the treatment of erectile dysfunction","volume":"4","author":"Coward","year":"2008","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"2026020606574998700_ref191","doi-asserted-by":"publisher","first-page":"e2036337","DOI":"10.1001\/jamanetworkopen.2020.36337","article-title":"Assessment of combination therapies vs monotherapy for erectile dysfunction: a systematic review and meta-analysis","volume":"4","author":"Mykoniatis","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026020606574998700_ref192","doi-asserted-by":"publisher","volume-title":"The Aging Male","DOI":"10.1080\/13685538.2019.1575354"},{"issue":"2","key":"2026020606574998700_ref193","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/tam.6.2.94.99","article-title":"Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone","volume":"6","author":"Kalinchenko","year":"2003","journal-title":"Aging Male"},{"issue":"4","key":"2026020606574998700_ref194","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/sj.ijir.3901446","article-title":"Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone","volume":"18","author":"Hwang","year":"2006","journal-title":"Int J Impot Res"},{"issue":"5","key":"2026020606574998700_ref195","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1439-0272.2009.00991.x","article-title":"Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone","volume":"43","author":"Garcia","year":"2011","journal-title":"Andrologia"},{"key":"2026020606574998700_ref196","volume-title":"LEVITRA (Vardenafil HCl) Tablets [Package Insert]","author":"U.S. Food and Drug Administration","year":"2014"},{"key":"2026020606574998700_ref197"},{"issue":"2","key":"2026020606574998700_ref198","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and Management of Testosterone Deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J Urol"},{"issue":"2","key":"2026020606574998700_ref199","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1743-6109.2012.02853.x","article-title":"IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men","volume":"10","author":"Zitzmann","year":"2013","journal-title":"J Sex Med"},{"key":"2026020606574998700_ref200","doi-asserted-by":"publisher","first-page":"735708","DOI":"10.3389\/fphar.2021.735708","article-title":"The effect of phosphodiesterase-type 5 inhibitors on erectile function: an overview of systematic reviews","volume":"12","author":"Pyrgidis","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"2026020606574998700_ref201","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.eururo.2013.01.012","article-title":"Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis","volume":"63","author":"Yuan","year":"2013","journal-title":"Eur Urol"},{"issue":"9","key":"2026020606574998700_ref202","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1080\/17512433.2016.1195261","article-title":"Avanafil - a further step to tailoring patient needs and expectations","volume":"9","author":"Boeri","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"2026020606574998700_ref203","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/iju.14785","article-title":"Efficacy and safety of avanafil as compared with sildenafil in the treatment of erectile dysfunction: a randomized, double blind, multicenter clinical trial","volume":"29","author":"Kumar","year":"2022","journal-title":"Int J Urol"},{"issue":"1","key":"2026020606574998700_ref204","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/and.12216","article-title":"Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction","volume":"47","author":"Cui","year":"2015","journal-title":"Andrologia"},{"issue":"3","key":"2026020606574998700_ref205","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1464-410X.2008.07610.x","article-title":"Can the international index of erectile function distinguish between organic and psychogenic erectile function?","volume":"102","author":"Deveci","year":"2008","journal-title":"BJU Int"},{"issue":"5","key":"2026020606574998700_ref206","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1046\/j.1365-2265.2003.01764.x","article-title":"Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction","volume":"58","author":"Aversa","year":"2003","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2026020606574998700_ref207","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/01.ju.0000132389.97804.d7","article-title":"Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone","volume":"172","author":"Shabsigh","year":"2004","journal-title":"J Urol"},{"issue":"4","key":"2026020606574998700_ref208","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1743-6109.2005.00071.x","article-title":"Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: a pilot study","volume":"2","author":"Shamloul","year":"2005","journal-title":"J Sex Med"},{"issue":"1","key":"2026020606574998700_ref209","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ijir.2012.32","article-title":"Combination therapy of testosterone enanthate and tadalafil on PDE5 inhibitor non-reponders with severe and intermediate testosterone deficiency","volume":"25","author":"Kim","year":"2013","journal-title":"Int J Impot Res"},{"issue":"4","key":"2026020606574998700_ref210","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0022-5347(05)67140-6","article-title":"Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year","volume":"164","author":"Hatzichristou","year":"2000","journal-title":"J Urol"},{"key":"2026020606574998700_ref211","author":"CAVERJECT"},{"issue":"14","key":"2026020606574998700_ref212","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1056\/NEJM199604043341401","article-title":"Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil study group","volume":"334","author":"Linet","year":"1996","journal-title":"N Engl J Med"},{"issue":"4","key":"2026020606574998700_ref213","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.ijir.3900365","article-title":"Intracavernous Alprostadil Alfadex\u2014an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study","volume":"10","author":"Porst","year":"1998","journal-title":"Int J Impot Res"},{"issue":"2","key":"2026020606574998700_ref214","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1743-6109.2006.00260.x","article-title":"Intracavernous injections of prostaglandin E1 for erectile dysfunction: patient satisfaction and quality of sex life on long-term treatment","volume":"4","author":"Alexandre","year":"2007","journal-title":"J Sex Med"},{"issue":"3","key":"2026020606574998700_ref215","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S0022-5347(01)66315-8","article-title":"The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience","volume":"155","author":"Porst","year":"1996","journal-title":"J Urol"},{"issue":"5","key":"2026020606574998700_ref216","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ijir.2012.15","article-title":"Pharmaco-induced erections for penile color-duplex ultrasound: oral PDE5 inhibitors or intracavernosal injection?","volume":"24","author":"Yang","year":"2012","journal-title":"Int J Impot Res"},{"issue":"1","key":"2026020606574998700_ref217","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/smrj.35","article-title":"Intracavernosal injection for the diagnosis, evaluation, and treatment of erectile dysfunction: a review","volume":"3","author":"Belew","year":"2015","journal-title":"Sex Med Rev"},{"issue":"1","key":"2026020606574998700_ref218","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0022-5347(17)48774-X","article-title":"Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence","volume":"133","author":"Zorgniotti","year":"1985","journal-title":"J Urol"},{"issue":"2","key":"2026020606574998700_ref219","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/17425255.2019.1560421","article-title":"Pharmacodynamics of the agents used for the treatment of erectile dysfunction","volume":"15","author":"Le","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"2026020606574998700_ref220","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.esxm.2016.08.001","article-title":"An empirical vs risk-based approach algorithm to Intracavernosal injection therapy: a prospective study","volume":"5","author":"Bernie","year":"2017","journal-title":"Sex Med"},{"issue":"6","key":"2026020606574998700_ref221","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00345-019-02727-5","article-title":"Erectile dysfunction: a global review of intracavernosal injectables","volume":"37","author":"Duncan","year":"2019","journal-title":"World J Urol"},{"issue":"3","key":"2026020606574998700_ref222","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0022-5347(01)66964-7","article-title":"Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study","volume":"154","author":"Shenfeld","year":"1995","journal-title":"J Urol"},{"issue":"3","key":"2026020606574998700_ref223","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0022-5347(01)66344-4","article-title":"Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses","volume":"155","author":"Bechara","year":"1996","journal-title":"J Urol"},{"issue":"4","key":"2026020606574998700_ref224","first-page":"355","article-title":"Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction","volume":"54","author":"Ribe","year":"2001","journal-title":"Arch Esp Urol"},{"issue":"11","key":"2026020606574998700_ref225","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/j.1464-410X.2012.11080.x","article-title":"A review of outcomes of an intracavernosal injection therapy programme","volume":"110","author":"Coombs","year":"2012","journal-title":"BJU Int"},{"issue":"S3","key":"2026020606574998700_ref226","first-page":"28","article-title":"The medical and surgical treatment of erectile dysfunction: a review and update","volume":"27","author":"Karakus","year":"2020","journal-title":"Can J Urol"},{"issue":"6","key":"2026020606574998700_ref227","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0022-5347(17)38167-3","article-title":"An improved vasoactive drug combination for a pharmacological erection program","volume":"146","author":"Bennett","year":"1991","journal-title":"J Urol"},{"issue":"6","key":"2026020606574998700_ref228","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/S0022-5347(01)64694-9","article-title":"Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction","volume":"157","author":"Bechara","year":"1997","journal-title":"J Urol"},{"issue":"5","key":"2026020606574998700_ref229","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0022-5347(01)64122-3","article-title":"Atropine role in the pharmacological erection test: study of 228 patients","volume":"158","author":"Sogari","year":"1997","journal-title":"J Urol"},{"issue":"4","key":"2026020606574998700_ref230","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0090-4295(00)00749-4","article-title":"Three-year outcome of a progressive treatment program for erectile dysfunction with intracavernous injections of vasoactive drugs","volume":"56","author":"Baniel","year":"2000","journal-title":"Urology"},{"issue":"5 Part 2","key":"2026020606574998700_ref231","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S0022-5347(17)36371-1","article-title":"Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction","volume":"149","author":"Montorsi","year":"1993","journal-title":"J Urol"},{"issue":"8","key":"2026020606574998700_ref232","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/14656566.2023.2204189","article-title":"Current status of intracavernosal injection therapy in erectile dysfunction","volume":"24","author":"Elena","year":"2023","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"2026020606574998700_ref233","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0091-3057(77)90224-6","article-title":"Drugs affecting dopamine neurons and yawning behavior","volume":"7","author":"Mogilnicka","year":"1977","journal-title":"Pharmacol Biochem Behav"},{"key":"2026020606574998700_ref234","first-page":"241","article-title":"Penile erection induced by apomorphine and Nn-propyl-norapomorphine in rats","volume":"242","author":"Benassi-Benelli","year":"1979","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"6","key":"2026020606574998700_ref235","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/BF01947317","article-title":"Behavioural effects of naloxone in rats","volume":"34","author":"Bertolini","year":"1978","journal-title":"Experientia"},{"key":"2026020606574998700_ref236","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ddstr.2005.05.005","article-title":"Male erectile dysfunction: chemical pharmacology of penile erection","volume":"2","author":"Argiolas","year":"2005","journal-title":"Drug Discov Today Ther Strateg"},{"issue":"3-4","key":"2026020606574998700_ref237","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0278-5846(89)90122-X","article-title":"Apomorphine: clinical studies on erectile impotence and yawning","volume":"13","author":"Lal","year":"1989","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"17","key":"2026020606574998700_ref238","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1073\/pnas.0308292101","article-title":"Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats","volume":"101","author":"Brioni","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020606574998700_ref239","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pbb.2015.08.012","article-title":"Role of dopamine D4 receptors in copulatory behavior: studies with selective D4 agonists and antagonists in male rats","volume":"137","author":"Sanna","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"2026020606574998700_ref240","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pbb.2005.03.012","article-title":"Dopamine D2, but not D4, receptor agonists are emetogenic in ferrets","volume":"81","author":"Osinski","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"15","key":"2026020606574998700_ref241","doi-asserted-by":"publisher","first-page":"12152","DOI":"10.3390\/ijms241512152","article-title":"Melanocortin 1 receptor (MC1R): pharmacological and therapeutic aspects","volume":"24","author":"Mun","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2026020606574998700_ref242","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1210\/er.2006-0034","article-title":"Studies on the physiological functions of the melanocortin system","volume":"27","author":"Cone","year":"2006","journal-title":"Endocr Rev"},{"issue":"4","key":"2026020606574998700_ref243","doi-asserted-by":"publisher","first-page":"T77","DOI":"10.1530\/JME-15-0323","article-title":"60 YEARS OF POMC: biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides","volume":"56","author":"Cawley","year":"2016","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"2026020606574998700_ref244","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0022-5347(01)62903-3","article-title":"Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study","volume":"160","author":"Wessells","year":"1998","journal-title":"J Urol"},{"issue":"4","key":"2026020606574998700_ref245","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0090-4295(00)00680-4","article-title":"Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction","volume":"56","author":"Wessells","year":"2000","journal-title":"Urology"},{"issue":"Suppl 4","key":"2026020606574998700_ref246","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1038\/sj.ijir.3900582","article-title":"Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II","volume":"12","author":"Wessells","year":"2000","journal-title":"Int J Impot Res"},{"issue":"1","key":"2026020606574998700_ref247","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/sj.ijir.3901139","article-title":"Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction","volume":"16","author":"Diamond","year":"2004","journal-title":"Int J Impot Res"},{"issue":"4S","key":"2026020606574998700_ref248","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0022-5347(18)33160-4","article-title":"924: SLX-2101, a new long-acting PDE5 inhibitor: preliminary safety, tolerability, PK and endothelial function effects in healthy subjects","volume":"175","author":"Prince","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"2026020606574998700_ref249","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.urology.2004.10.060","article-title":"Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response","volume":"65","author":"Diamond","year":"2005","journal-title":"Urology"},{"issue":"3","key":"2026020606574998700_ref250","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.juro.2007.10.063","article-title":"Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study","volume":"179","author":"Safarinejad","year":"2008","journal-title":"J Urol"},{"issue":"5","key":"2026020606574998700_ref251","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/jsm.12095","article-title":"Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure","volume":"10","author":"Albersen","year":"2013","journal-title":"J Sex Med"},{"issue":"2","key":"2026020606574998700_ref252","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3892\/etm.2013.1125","article-title":"The rho\/rho-associated protein kinase inhibitor fasudil in the protection of endothelial cells against advanced glycation end products through the nuclear factor \u03baB pathway","volume":"6","author":"Lu","year":"2013","journal-title":"Exp Ther Med"},{"issue":"11","key":"2026020606574998700_ref253","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrurol.2014.278","article-title":"Understanding and targeting the rho kinase pathway in erectile dysfunction","volume":"11","author":"Sopko","year":"2014","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2026020606574998700_ref254","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1124\/jpet.109.160606","article-title":"Up-regulation of the RhoA\/rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice","volume":"333","author":"Priviero","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"2026020606574998700_ref255","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.str.2003.11.002","article-title":"Protein kinase a in complex with rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity","volume":"11","author":"Breitenlechner","year":"2003","journal-title":"Structure"},{"issue":"1","key":"2026020606574998700_ref256","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1743-6109.2008.01057.x","article-title":"Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA\/rho-kinase signaling hyperactivation","volume":"6","author":"Morelli","year":"2009","journal-title":"J Sex Med"},{"issue":"6","key":"2026020606574998700_ref257","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/jsm.12134","article-title":"Activated rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation","volume":"10","author":"Toque","year":"2013","journal-title":"J Sex Med"},{"issue":"1","key":"2026020606574998700_ref258","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1475-2840-12-51","article-title":"Role of ROCK upregulation in endothelial and smooth muscle vascular functions in diabetic rat aorta","volume":"12","author":"Cicek","year":"2013","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"2026020606574998700_ref259","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1111\/jsm.12613","article-title":"Hydroxyl fasudil, an inhibitor of rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK","volume":"11","author":"Sezen","year":"2014","journal-title":"J Sex Med"},{"key":"2026020606574998700_ref260","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3389\/fphar.2020.01257","article-title":"Liraglutide ameliorates erectile dysfunction via regulating oxidative stress, the RhoA\/ROCK pathway and autophagy in diabetes mellitus","volume":"11","author":"Yuan","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"2026020606574998700_ref261","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.pa.30.040190.002535","article-title":"Biosynthesis and metabolism of endothelium-derived nitric oxide","volume":"30","author":"Ignarro","year":"1990","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5069","key":"2026020606574998700_ref262","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1126\/science.1353273","article-title":"Nitric oxide: first in a new class of neurotransmitters","volume":"257","author":"Snyder","year":"1992","journal-title":"Science"},{"issue":"5068","key":"2026020606574998700_ref263","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1126\/science.1378650","article-title":"Nitric oxide: a physiologic mediator of penile erection","volume":"257","author":"Burnett","year":"1992","journal-title":"Science"},{"issue":"11","key":"2026020606574998700_ref264","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.107.162511","article-title":"Phosphodiesterase type 5: expanding roles in cardiovascular regulation","volume":"101","author":"Kass","year":"2007","journal-title":"Circ Res"},{"key":"2026020606574998700_ref265","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0079-6468(02)41007-7","article-title":"Phosphodiesterase type 5 (PDE5) inhibitors","volume":"41","author":"Haning","year":"2003","journal-title":"Prog Med Chem"},{"issue":"3","key":"2026020606574998700_ref266","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/BF03401627","article-title":"Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase","volume":"2","author":"Burnett","year":"1996","journal-title":"Mol Med"},{"issue":"9","key":"2026020606574998700_ref267","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1073\/pnas.0511326103","article-title":"Alternatively spliced neuronal nitric oxide synthase mediates penile erection","volume":"103","author":"Hurt","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2026020606574998700_ref268","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3949\/ccjm.85a.18011","article-title":"Men's health 2018: BPH, prostate cancer, erectile dysfunction, supplements","volume":"85","author":"Chaitoff","year":"2018","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"2026020606574998700_ref269","doi-asserted-by":"publisher","first-page":"482","DOI":"10.5152\/tud.2021.21206","article-title":"Yohimbine as a treatment for erectile dysfunction: a systematic review and meta-analysis","volume":"47","author":"Wibowo","year":"2021","journal-title":"Turk J Urol"},{"key":"2026020606574998700_ref270","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-8022-7","volume-title":"Natural Small Molecule Drugs from Plants","author":"Du","year":"2018"},{"key":"2026020606574998700_ref271","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-981-10-8022-7_27","volume-title":"Natural Small Molecule Drugs from Plants","author":"Fu","year":"2018"},{"key":"2026020606574998700_ref272","first-page":"1476","article-title":"A systematic overview of reviews on the efficacy of complementary and alternative medicine in erectile dysfunction","volume":"6","author":"Irani","year":"2018","journal-title":"J Midwifery Reprod Health"},{"issue":"1","key":"2026020606574998700_ref273","doi-asserted-by":"publisher","DOI":"10.14200\/jrm.2019.0104","article-title":"Erectile dysfunction: a review of comprehensive treatment options for optimal outcome","volume":"8","author":"Retzler","year":"2019","journal-title":"J Restor Med"},{"issue":"2","key":"2026020606574998700_ref274","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0022-5347(01)63942-9","article-title":"Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials","volume":"159","author":"Ernst","year":"1998","journal-title":"J Urol"},{"issue":"5","key":"2026020606574998700_ref275","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/S0090-4295(94)80216-5","article-title":"Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study","volume":"44","author":"Montorsi","year":"1994","journal-title":"Urology"},{"issue":"6","key":"2026020606574998700_ref276","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/S0022-5347(17)44436-3","article-title":"Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial","volume":"137","author":"Morales","year":"1987","journal-title":"J Urol"},{"issue":"8556","key":"2026020606574998700_ref277","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0140-6736(87)90958-5","article-title":"Double-blind trial of yohimbine in treatment of psychogenic impotence","volume":"330","author":"Reid","year":"1987","journal-title":"Lancet"},{"issue":"1","key":"2026020606574998700_ref278","first-page":"1","article-title":"Efficacy and safety of oral combination of Yohimbine and L-arginine (SX) for the treatment of erectile dysfunction: a multicenter, randomized, double blind, placebo-controlled clinical trial","volume":"5","author":"Akhondzadeh","year":"2010","journal-title":"Iran J Psychiatry"},{"issue":"3","key":"2026020606574998700_ref279","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2165\/00002512-200724030-00001","article-title":"Might DHEA be considered a beneficial replacement therapy in the elderly?","volume":"24","author":"Genazzani","year":"2007","journal-title":"Drugs Aging"},{"issue":"3","key":"2026020606574998700_ref280","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1210\/jcem-59-3-551","article-title":"Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood","volume":"59","author":"Orentreich","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026020606574998700_ref281","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0047-6374(01)00369-4","article-title":"Uses of DHEA in aging and other disease states","volume":"1","author":"Johnson","year":"2002","journal-title":"Ageing Res Rev"},{"issue":"2","key":"2026020606574998700_ref282","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1530\/eje.0.1450103","article-title":"Dehydroepiandrosterone replacement therapy","volume":"145","author":"Gurnell","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026020606574998700_ref283","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.juro.2006.08.005","article-title":"Age related testosterone depletion in patients with erectile dysfunction","volume":"176","author":"El-Sakka","year":"2006","journal-title":"J Urol"},{"issue":"3","key":"2026020606574998700_ref284","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1177\/1557988316689238","article-title":"Psychobiological protective factors modifying the association between age and sexual health in men: findings from the men\u2019s health 40+ study","volume":"11","author":"Walther","year":"2017","journal-title":"Am J Mens Health"},{"issue":"7","key":"2026020606574998700_ref285","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3390\/nu11071679","article-title":"The effects of oral l-arginine and l-Citrulline supplementation on blood pressure","volume":"11","author":"Khalaf","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"2026020606574998700_ref286","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4081\/aiua.2015.3.190","article-title":"Improvement of seminal quality and sexual function of men with oligoasthenoteratozoospermia syndrome following supplementation with L-arginine and Pycnogenol(R)","volume":"87","author":"Kobori","year":"2015","journal-title":"Arch Ital Urol Androl"},{"issue":"04","key":"2026020606574998700_ref287","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5414\/CPP40158","article-title":"A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology","volume":"40","author":"Rohdewald","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"9","key":"2026020606574998700_ref288","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1291\/hypres.30.775","article-title":"Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans","volume":"30","author":"Nishioka","year":"2007","journal-title":"Hypertens Res"},{"issue":"3","key":"2026020606574998700_ref289","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/00926230390155104","article-title":"Treatment of erectile dysfunction with pycnogenol and L-arginine","volume":"29","author":"Stanislavov","year":"2003","journal-title":"J Sex Marital Ther"},{"key":"2026020606574998700_ref290","doi-asserted-by":"publisher","first-page":"1211720","DOI":"10.3389\/fendo.2023.1211720","article-title":"Efficacy of L-arginine and Pycnogenol (R) in the treatment of male erectile dysfunction: a systematic review and meta-analysis","volume":"14","author":"Tian","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2026020606574998700_ref291","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.3390\/app11073293","article-title":"L-Citrulline: a non-essential amino acid with important roles in human health","volume":"11","author":"Aguayo","year":"2021","journal-title":"Appl Sci"},{"key":"2026020606574998700_ref292","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.niox.2018.03.010","article-title":"Effect of ginger, Paullinia cupana, muira puama and l-citrulline, singly or in combination, on modulation of the inducible nitric oxide-NO-cGMP pathway in rat penile smooth muscle cells","volume":"76","author":"Ferrini","year":"2018","journal-title":"Nitric Oxide"},{"issue":"3","key":"2026020606574998700_ref293","doi-asserted-by":"publisher","first-page":"e26391","DOI":"10.4161\/spmg.26391","article-title":"Ginseng and male reproductive function","volume":"3","author":"Leung","year":"2013","journal-title":"Spermatogenesis"},{"issue":"4","key":"2026020606574998700_ref294","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1365-2125.2008.03236.x","article-title":"Red ginseng for treating erectile dysfunction: a systematic review","volume":"66","author":"Jang","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"2026020606574998700_ref295","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11934-019-0908-2","article-title":"Emerging treatments for erectile dysfunction: a review of novel, non-surgical options","volume":"20","author":"Patel","year":"2019","journal-title":"Curr Urol Rep"},{"issue":"2","key":"2026020606574998700_ref296","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1745-7262.2007.00210.x","article-title":"Study of the efficacy of Korean red ginseng in the treatment of erectile dysfunction","volume":"9","author":"de Andrade","year":"2007","journal-title":"Asian J Androl"},{"issue":"2","key":"2026020606574998700_ref297","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4081\/aiua.2021.2.221","article-title":"A new original nutraceutical formulation ameliorates the effect of Tadalafil on clinical score and cGMP accumulation","volume":"93","author":"Mirone","year":"2021","journal-title":"Arch Ital Urol Androl"},{"issue":"2","key":"2026020606574998700_ref298","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/uro2020009","article-title":"Effectiveness of ginseng, rutin and moringa for the treatment of erectile dysfunction: a systematic review","volume":"2","author":"Rebez","year":"2022","journal-title":"Uro"},{"issue":"4_Part_1","key":"2026020606574998700_ref299","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/j.1743-6109.2009.01699.x","article-title":"Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo","volume":"7","author":"Shindel","year":"2010","journal-title":"J Sex Med"},{"issue":"14","key":"2026020606574998700_ref300","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/BF02900599","article-title":"Icariin on relaxation effect of corpus cavernosum smooth muscle","volume":"46","author":"Xin","year":"2001","journal-title":"Chin Sci Bull"},{"issue":"4","key":"2026020606574998700_ref301","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.eururo.2008.06.083","article-title":"Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy","volume":"54","author":"Montorsi","year":"2008","journal-title":"Eur Urol"},{"issue":"4","key":"2026020606574998700_ref302","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1745-7262.2005.00066.x","article-title":"Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats","volume":"7","author":"Liu","year":"2005","journal-title":"Asian J Androl"},{"issue":"1","key":"2026020606574998700_ref303","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3928\/0191-3913-19800101-06","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"17","author":"Scott","year":"1980","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"S4","key":"2026020606574998700_ref304","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1002\/nau.23552","article-title":"What is the exact working mechanism of botulinum toxin a and sacral nerve stimulation in the treatment of overactive bladder\/detrusor overactivity? ICI-RS 2017","volume":"37","author":"Malde","year":"2018","journal-title":"Neurourol Urodyn"},{"issue":"6S","key":"2026020606574998700_ref305","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.juro.2012.09.079","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline","volume":"188","author":"Gormley","year":"2012","journal-title":"J Urol"},{"issue":"2","key":"2026020606574998700_ref306","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/andr.13104","article-title":"Safety and efficacy of botulinum neurotoxin in the treatment of erectile dysfunction refractory to phosphodiesterase inhibitors: results of a randomized controlled trial","volume":"10","author":"Abdelrahman","year":"2022","journal-title":"Andrology"},{"issue":"4","key":"2026020606574998700_ref307","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/andr.13010","article-title":"Intra-cavernous injection of BOTOX((R)) (50 and 100 units) for treatment of vasculogenic erectile dysfunction: randomized controlled trial","volume":"9","author":"El-Shaer","year":"2021","journal-title":"Andrology"},{"issue":"7","key":"2026020606574998700_ref308","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1185\/030079904125003962","article-title":"Safety of botulinum toxin type a: a systematic review and meta-analysis","volume":"20","author":"Naumann","year":"2004","journal-title":"Curr Med Res Opin"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/13\/4\/513\/63925074\/qeaf035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/13\/4\/513\/63925074\/qeaf035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:58:02Z","timestamp":1770379082000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smr\/article\/13\/4\/513\/8221489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,3]]},"references-count":311,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10,4]]}},"URL":"https:\/\/doi.org\/10.1093\/sxmrev\/qeaf035","relation":{},"ISSN":["2050-0513","2050-0521"],"issn-type":[{"value":"2050-0513","type":"print"},{"value":"2050-0521","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,8,3]]}}}